首页> 外文会议>the European Peptide Symposium >STRUCTURAL VARIATION IN E3 LIGASES UBIQUITINATION PLATFORM
【24h】

STRUCTURAL VARIATION IN E3 LIGASES UBIQUITINATION PLATFORM

机译:E3连接酶泛素突出平台的结构变异

获取原文

摘要

p53 is a tumor suppressor protein, called also "The Guardian of the cells and genome" and one of the most effective defensive weapons of human body against carcinogenesis. Activation and/or inactivation of p53 is a critical step in the tumor suppression/formation process, respectively. The suppression of p53 levels is being indirectly regulated by the protein itself, which activates the expression of the oncogene mdm2 (murine double minute 2), which expresses the HDM2 protein. HDMX, a HDM2 homologue, is also being implicated in p53 suppression. The C-terminal regions of HDM2 and HDMX are RING finger domains and catalyze the last stage of protein signaling for proteolysis, through the ubiquitin pathway acting therefore as E3 ubiquitin ligases. The activity of p53 as a transcription factor is strongly coupled to HDM2 protein overexpression which is a molecular mechanism of the cell towards p53 ubiquitinylation, degradation and inactivation.
机译:P53是一种肿瘤抑制蛋白,也称为“细胞和基因组的监护人”,以及对致癌的人体最有效的防御性武器之一。 P53的激活和/或失活度分别是肿瘤抑制/形成过程中的关键步骤。蛋白质本身间接调节p53水平的抑制,其激活癌基因MDM2(鼠双分钟2)的表达,其表达HDM2蛋白。 HDMX,一种HDM2同源物,也涉及P53抑制。 HDM2和HDMX的C末端区域是环形指导区域,并催化蛋白质信号传导的最后阶段,用于蛋白水解,通过泛素途径作为E3泛素连接酶。 P53作为转录因子的活性强烈地偶联到HDM2蛋白过表达,其是细胞朝向P53 ubquitinylation,降解和灭活的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号